Skip to Main Content
Urinary incontinence happens when you lose bladder control or you leak urine involuntarily. It affects 9 million to 13 million people of all ages in the United States. The majority are women, and it is most common among elderly women. The more times a woman has given birth, the more her risk of urinary incontinence goes up. Smoking is also a risk factor.
Most of these women have stress incontinence, where you leak urine when you laugh, cough, sneeze, or exercise. Another type is urge incontinence, when you may have to "go" suddenly and can't hold the urine in. Some women have both types. Some people may experience temporary incontinence.
Signs and Symptoms
What Causes It?
What to Expect at Your Provider's Office
Your doctor will give you a physical examination and ask questions about:
You may be asked to cough vigorously to see if it causes urine loss. This is a sign of stress incontinence.
Your doctor may suggest urine tests to find:
A pelvic ultrasound may be done to look at your bladder, kidneys, and urethra.
Treatment can help more than 80% of people with urinary incontinence. Exercise and behavioral therapies are most successful. But there are also several drugs available to help with urge incontinence, including:
Options for urge incontinence that hasn't responded to medication include:
Surgery may help women with stress incontinence and men with an enlarged prostate. Other options include:
Recent studies suggest that midurethral slings are the most commonly performed surgical treatments for stress incontinence.
Complementary and Alternative Therapies
Common alternative therapies include:
Other alternative therapies include:
Always tell your doctor about the herbs and supplements you are using.
Nutrition and Supplements
One study suggested that chondroitin sulfate helped with symptoms or urge incontinence and overactive bladder, as well as the medication Detrol. More studies are needed to know whether it really works. Avoid chondroitin sulfate if you are allergic to shellfish or have asthma. Chondroitin sulfate can increase the risk of bleeding, especially if you take blood thinners such as warfarin (Coumadin) or clopidogrel (Plavix). Pregnant or breastfeeding women should not take chondroitin sulfate. Men with prostate cancer should ask their doctor before taking chondroitin.
Herbs are a way to strengthen and tone the body's systems. As with any therapy, you should work with your doctor to diagnose your problem before starting treatment. You may use herbs as dried extracts (capsules, powders, teas), glycerites (glycerine extracts), or tinctures (alcohol extracts). Unless otherwise indicated, make teas with 1 tsp. herb per cup of hot water. Steep covered 5 to 10 minutes for leaf or flowers, and 10 to 20 minutes for roots. Drink 2 to 4 cups per day. You may use tinctures alone or in combination as noted. Speak to your doctor about any herbal therapies you are considering.
One laboratory study suggested that St. John's wort (Hypericum perforatum) has the potential to help with urinary incontinence. But this use has not been tested in humans. St. John's wort can interfere with many medications. Check with your doctor before taking St. John's wort if you are taking prescription medications, including birth control pills. St. John's wort can affect mood, so people with a history of psychiatric illness should ask their doctors before taking it. Don't take St. John's wort if you are trying to become pregnant or if you have a history of liver disease.
The following are some of the most common remedies used for urinary incontinence. Usually, the dose is 3 to 5 pellets of a 12X to 30C remedy every 1 to 4 hours until symptoms improve.
Acupuncture may help, depending on what's causing the incontinence. Acupuncture may also strengthen the urinary system. In one study, women who received 4 weekly bladder acupuncture treatments had significant improvement in symptoms of urinary incontinence compared to women who received placebo treatments.
Exercise and behavioral therapy can help many people get rid of their symptoms. You have to stick with the changes for them to work, so it may help to have support from a loved one and close monitoring by your doctor.
If you are pregnant, consult with your doctor before taking any medication. For men, regular prostate examinations can find problems early. If the condition worsens, patients may suffer from depression, recurrent urinary tract infections, and social isolation.
Abed H, Rogers R. Urinary Incontinence and Pelvic Organ Prolapse: Diagnosis and Treatment for the Primary Care Physician. Medical Clinics of North America. 2008;92(5).
Barbosa AM, Marini G, Piculo F, Rudge CV, Calderon IM, Rudge MV. Prevalence of urinary incontinence and pelvic floor muscle dysfunction in primiparae two years after cesarean section: cross-sectional study. Sao Paulo Med J. 2013; 131(2):95-9.
Buchsbaum GM. Urinary incontinence and pelvic organ prolapse. Minerva Urol Nefrol. 2006;58(4):311-19.
Burgio K. Behavioral Treatment of Urinary Incontinence, Voiding Dysfunction, and Overactive Bladder. Obstetrics and Gynecology Clinics. 2009;36(3).
Capasso R, Borrelli F, Capasso F, et al. Inhibitory effect of the antidepressant St. John's wort (hypericum perforatum) on rat bladder contractility in vitro. Urology. 2004;64(1):168-72.
Cherniack EP. Biofeedback and other therapies for the treatment of urinary incontinence in the elderly. Altern Med Rev. 2006;11(3):224-31.
Chuang CM, Lin IF, Horng HC, Hsiao YH, Shyu IL, Chou P. The impact of gestational diabetes mellitus on postpartum urinary incontinence: a longitudinal cohort study on singleton pregnancies. BJOG. 2012; 119(11):1334-43.
Courtesse A, Cardot V. Recommendations for the clinical evaluation of non-neurological female urinary incontinence. Prog Urol. 2007;17(6 Suppl 2):1242-51.
Davis NJ, Vaughan CP, Johnson TM, et al. Caffeine intake and its association with urinary incontinence in United States men: results from National Health and Nutrition Examination Surveys 2005-2006 and 2007-2008. J Urol. 2013; 189(6):2170-4.
Dean NM, Ellis G, Wilson PD, Herbison GP. Laparoscopic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev. 2006;3:CD002239.
Devore EE, Townsend MK, Resnick NM, Grodstein F. The epidemiology of urinary incontinence in women with type 2 diabetes. J Urol. 2012; 188(5):1816-21.
Doron S, Gorbach SL. Probiotics: their role in the treatment and prevention of disease. Expert Rev Anti Infect Ther. 2006;4(2):261-75.
Dryden GW Jr, Deaciuc I, Arteel G, McClain CJ. Clinical implications of oxidative stress and antioxidant therapy. Curr Gastroenterol Rep. 2005;7(4):308-16.
Djavan B. Lower urinary tract symptoms/benign prostatic hyperplasia: fast control of the patient's quality of life. Urology. 2003;62(3 Suppl 1):6-14.
Emmons SL, Otto L. Acupuncture for overactive bladder: a randomized controlled trial. Obstet Gynecol. 2005;106(1):138-43.
Erdem N, Chu FM. Management of overactive bladder and urge urinary incontinence in the elderly patient. Am J Med. 2006;119(3 Suppl 1):29-36.
Fan HL, Chan SS, Law TS, Cheung RY, Chung TK. Pelvic floor muscle training improves quality of life of women with urinary incontinence: a prospective study. Aust N Z J Obstet Gynaecol. 2013; 53(3):298-304.
Ferri. Ferri's Clinical Advisor 2014. 1st ed. Philadelphia, PA: Mosby, An Imprint of Elsevier; 2013.
Gauruder-Burmester A, Wildt B, Tunn R. Treatment of overactive bladder with sodium chondroitin sulphate. Zentralbl Gynakol. 2006 Dec;128(6):336-40.
Griebling T. Urinary Incontinence in the Elderly. Clinics in Geriatric Medicine. B. Saunders Company. Philadelphia, PA: 2009; 25(3).
Hashim H, Abrams P. Pharmacological management of women with mixed urinary incontinence. Drugs. 2006;66(5):591-606.
Hay-Smith EJ, Dumoulin C. Pelvic floor muscle training versus no treatment, or inactive control treatments for urinary incontinence in women. Cochrane Database Syst Rev. 2006;(1):CD005654.
Hermieu JF. Recommendations for the urodynamic examination in the investigation of non-neurological female urinary incontinence. Prog Urol. 2007;17(6 Suppl 2):1264-84.
Hersh L, Salzman B. Clinical management of urinary incontinence in women. Am Fam Physician. 2013; 87(9):634-40.
Holroyd-Leduc JM, Tannenbaum C, Thorpe KE, Straus SE. What type of urinary incontinence does this woman have? JAMA. 2008;299(12):1446-56.
Lee E, Nitti V, Brucker B. Midurethral Slings for All Stress Incontinence. Urologic Clinics of North America. Philadelphia, PA: W. B. Saunders. 2012; 39(3).
Matthews CA, Whitehead WE, Townsend MK, Grodstein F. Risk factors for urinary, fecal, and dual incontinence in the Nurses' Health Study. Obstet Gynecol. 2013; 122(3):539-45.
McKertich K. Urinary incontinence-assessment in women: stress, urge or both? Aust Fam Physician. 2008;37(3):112-7.
Naranjo-Ortiz C, Clemente-Ramos LM, Salinas-Casado J, Mendez-Rubio S. Urodynamic approach to female urinary incontinence refractory to treatment with anticholinergics. Arch Esp Urol. 2012; 65(10):879-86.
Smith PP, McCrery RJ, Appell RA. Current trends in the evaluation and management of female urinary incontinence. CMAJ. 2006;175(10):1233-40.
Yoon JH, Baek SJ. Molecular targets of dietary polyphenols with anti-inflammatory properties. Yonsei Med J. 2005;46(5):585-96.
Review Date: 3/5/2014
Reviewed By: Steven D. Ehrlich, NMD, Solutions Acupuncture, a private practice specializing in complementary and alternative medicine, Phoenix, AZ. Review provided by VeriMed Healthcare Network.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.